Equasens (FRA:PHF) Valuation Rank


FRA:PHF Equasens FRA:PHF
93 GF Score
Price €52.77
GF Value €85.23
! 2 Warning Signs
View Full Analysis

What is Equasens Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Equasens Valuation Rank Related Terms

FRA:PHF
93GF Score
Equasens FRA:PHF
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Equasens (FRA:PHF) Overvalued in 2026?

Based on GuruFocus' analysis, Equasens stock appears to be undervalued. The current stock price of €52.77 is trading 38.1% below its estimated GF Value™ of €85.23.

Key valuation signals for FRA:PHF:

  • Valuation Rank:
  • GF Value™: €85.23 vs. price of €52.77 (38.1% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the FRA:PHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Equasens Business Description

Address 5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
93GF Score

Get the complete analysis for FRA:PHF

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€52.77
Price
€85.23
GF Value